These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 21904068)

  • 1. Resection status, age and nodal involvement determine survival among patients receiving adjuvant chemoradiotherapy in pancreatic adenocarcinoma.
    Moghanaki D; Mick R; Furth EE; Sohal D; Salmon PM; Behbahani A; Morgans AK; Miller SM; Giantonio BJ; Whittington RW; Haller DG; Rosato EF; Plastaras JP
    JOP; 2011 Sep; 12(5):438-44. PubMed ID: 21904068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative CA 19-9 level is an important prognostic factor in patients with pancreatic adenocarcinoma treated with surgical resection and adjuvant concurrent chemoradiotherapy.
    Hallemeier CL; Botros M; Corsini MM; Haddock MG; Gunderson LL; Miller RC
    Am J Clin Oncol; 2011 Dec; 34(6):567-72. PubMed ID: 21150564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant radiotherapy and chemotherapy for pancreatic carcinoma: the Mayo Clinic experience (1975-2005).
    Corsini MM; Miller RC; Haddock MG; Donohue JH; Farnell MB; Nagorney DM; Jatoi A; McWilliams RR; Kim GP; Bhatia S; Iott MJ; Gunderson LL
    J Clin Oncol; 2008 Jul; 26(21):3511-6. PubMed ID: 18640932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant chemoradiotherapy after curative resection for extrahepatic bile duct cancer: a long-term single center experience.
    Kim K; Chie EK; Jang JY; Kim SW; Han SW; Oh DY; Im SA; Kim TY; Bang YJ; Ha SW
    Am J Clin Oncol; 2012 Apr; 35(2):136-40. PubMed ID: 21325937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of resection margin status and postoperative CA19-9 levels on survival and patterns of recurrence after postoperative high-dose radiotherapy with 5-FU-based concurrent chemotherapy for resectable pancreatic cancer.
    Kinsella TJ; Seo Y; Willis J; Stellato TA; Siegel CT; Harpp D; Willson JK; Gibbons J; Sanabria JR; Hardacre JM; Schulak JP
    Am J Clin Oncol; 2008 Oct; 31(5):446-53. PubMed ID: 18838880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does preoperative therapy optimize outcomes in patients with resectable pancreatic cancer?
    Papalezova KT; Tyler DS; Blazer DG; Clary BM; Czito BG; Hurwitz HI; Uronis HE; Pappas TN; Willett CG; White RR
    J Surg Oncol; 2012 Jul; 106(1):111-8. PubMed ID: 22311829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible?
    Schnelldorfer T; Ware AL; Sarr MG; Smyrk TC; Zhang L; Qin R; Gullerud RE; Donohue JH; Nagorney DM; Farnell MB
    Ann Surg; 2008 Mar; 247(3):456-62. PubMed ID: 18376190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of total lymph node count and lymph node ratio on staging and survival after pancreatectomy for pancreatic adenocarcinoma: a large, population-based analysis.
    Slidell MB; Chang DC; Cameron JL; Wolfgang C; Herman JM; Schulick RD; Choti MA; Pawlik TM
    Ann Surg Oncol; 2008 Jan; 15(1):165-74. PubMed ID: 17896141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nodal involvement is strongest predictor of poor survival in patients with invasive adenocarcinoma of the head of the pancreas.
    Nakagohri T; Kinoshita T; Konishi M; Takahashi S; Gotohda N
    Hepatogastroenterology; 2006; 53(69):447-51. PubMed ID: 16795990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer.
    Pawlik TM; Gleisner AL; Cameron JL; Winter JM; Assumpcao L; Lillemoe KD; Wolfgang C; Hruban RH; Schulick RD; Yeo CJ; Choti MA
    Surgery; 2007 May; 141(5):610-8. PubMed ID: 17462460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival effects of adjuvant chemoradiotherapy after resection for pancreatic carcinoma.
    Yang R; Cheung MC; Byrne MM; Jin X; Montero AJ; Jones C; Koniaris LG
    Arch Surg; 2010 Jan; 145(1):49-56. PubMed ID: 20083754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant chemotherapy and surgery for esophageal adenocarcinoma: prognostic value of circumferential resection margin and stratification of N1 category.
    Saha AK; Sutton C; Rotimi O; Dexter S; Sue-Ling H; Sarela AI
    Ann Surg Oncol; 2009 May; 16(5):1364-70. PubMed ID: 19252949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review of adjuvant radiochemotherapy for resected pancreatic cancer and results from Mayo Clinic for the 5th JUCTS symposium.
    Miller RC; Iott MJ; Corsini MM
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):364-8. PubMed ID: 19735864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
    Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Borderline and locally advanced pancreatic adenocarcinoma margin accentuation with intraoperative irreversible electroporation.
    Kwon D; McFarland K; Velanovich V; Martin RC
    Surgery; 2014 Oct; 156(4):910-20. PubMed ID: 25239345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long term survival after pancreatic resection for pancreatic adenocarcinoma.
    Ahmad NA; Lewis JD; Ginsberg GG; Haller DG; Morris JB; Williams NN; Rosato EF; Kochman ML
    Am J Gastroenterol; 2001 Sep; 96(9):2609-15. PubMed ID: 11569683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular metastases in stage I pancreatic cancer: improved survival with adjuvant chemoradiation.
    Demeure MJ; Doffek KM; Komorowski RA; Redlich PN; Zhu YR; Erickson BA; Ritch PS; Pitt HA; Wilson SD
    Surgery; 1998 Oct; 124(4):663-9. PubMed ID: 9780986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of paraaortic lymph node involvement on early recurrence and survival after macroscopic curative resection with extended lymphadenectomy for pancreatic carcinoma.
    Shimada K; Sakamoto Y; Sano T; Kosuge T
    J Am Coll Surg; 2006 Sep; 203(3):345-52. PubMed ID: 16931307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative versus postoperative chemoradiation for patients with resected pancreatic adenocarcinoma.
    Pendurthi TK; Hoffman JP; Ross E; Johnson DE; Eisenberg BL
    Am Surg; 1998 Jul; 64(7):686-92. PubMed ID: 9655283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.